NANO MRNA Co.,Ltd. (TYO:4571)
Japan
· Delayed Price · Currency is JPY 133.00
-1.00 (-0.75%)
May 2, 2025, 3:30 PM JST
NANO MRNA Revenue
NANO MRNA had revenue of 76.00M JPY in the quarter ending December 31, 2024, with 484.62% growth. This brings the company's revenue in the last twelve months to 114.00M, down -30.49% year-over-year. In the fiscal year ending March 31, 2024, NANO MRNA had annual revenue of 135.00M, down -33.17%.
Revenue (ttm)
114.00M
Revenue Growth
-30.49%
P/S Ratio
82.37
Revenue / Employee
6.33M
Employees
18
Market Cap
9.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |